In vitro activity of BMY-28100 against common isolates from pediatric infections | Zendy

R K Scribner | Zendy; Melvin I. Marks | Zendy; Brad D. Finkhouse | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro activity of BMY-28100 against common isolates from pediatric infections

Author(s) -

R K Scribner,

Melvin I. Marks,

Brad D. Finkhouse

Publication year - 1987

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.31.4.630

Subject(s) - cefaclor , cephalosporin , agar dilution , antibacterial activity , microbiology and biotechnology , agar dilution method , in vitro , antibacterial agent , biology , agar , antibiotics , bacteria , minimum inhibitory concentration , biochemistry , genetics

The antibacterial activity of BMY-28100, a new oral cephalosporin, was measured against 300 bacterial isolates from pediatric infections by standard agar dilution methodology. The effect of inoculum size on activity was also assessed. BMY-28100 was more active than cephalexin or cefaclor against all bacterial species tested.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research